| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697284 | Bulletin du Cancer | 2017 | 14 Pages |
Abstract
The reform of modalities of inscription on the list of onerous drugs represents a significant additional cost for health institutions (1.1 million euros for our hospital) and raises the question of the accessibility to these treatments for cancer patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Amandine Baudouin, Emilie Fargier, Ariane Cerruti, Amélie Dubromel, Nicolas Vantard, Florence Ranchon, Vérane Schwiertz, Gilles Salles, Pierre-Jean Souquet, Luc Thomas, Frédéric Bérard, Stéphane Nancey, Gilles Freyer, Véronique Trillet-Lenoir,